Xianyu Sun

Dr. Xianyu Sun


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
GJGuofan Jin
Guofan Jin
ZLZhenwang Li
Zhenwang Li
FXFuyan Xiao
Fuyan Xiao
XQXueyong Qi
Xueyong Qi
XSXianyu Sun
Xianyu Sun

18 February 2020 in ChemMedChem
Verified
Journal Article
Open access
PDF file
GJGuofan Jin
Guofan Jin
FXFuyan Xiao
Fuyan Xiao
ZLZhenwang Li
Zhenwang Li
XQXueyong Qi
Xueyong Qi
LZLei Zhao
Lei Zhao
XSXianyu Sun
Xianyu Sun
A series of novel quinoline and quinolinium iodide derivatives were designed and synthesized to discover potential anticancer and antibacterial agents. With regard to anticancer properties, in vitro cytotoxicities against three human cancer cell lines (A‐549, HeLa and SGC‐7901) were evaluated. The antibacterial properties against two strains,Escherichia coli(ATCC 29213) andStaphylococcus aureus(ATCC 8739), along with minimum inhibitory concentration (MIC) values were evaluated. The target alkyliodine substituted compounds exhibited significant antitumor and antibacterial activity, of which compound 8‐((4‐(benzyloxy)phenyl)amino)‐7‐(ethoxycarbonyl)‐5‐propyl‐[1,3]dioxolo[4,5‐g]quinolin‐5‐ium (12) was found to be the most potent derivative with IC50values of 4.45±0.88, 4.74±0.42, 14.54±1.96, and 32.12±3.66 against A‐549, HeLa, SGC‐7901, and L‐02 cells, respectively, stronger than the positive controls 5‐FU and MTX. Furthermore, compound12had the most potent bacterial inhibitory activity. The MIC of this compound against bothE. coliandS. aureuswas 3.125 nmol ⋅ mL−1, which was smaller than that against the reference agents amoxicillin and ciprofloxacin.

1 February 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XSXianyu Sun
Xianyu Sun
RWRui Wu
Rui Wu
XWXiang Wen
Xiang Wen
LGLi Guo
Li Guo
CZChang-Ping Zhou
Chang-Ping Zhou
JBJun Bao
Jun Bao

1 December 2011 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
XSXianyu Sun
Xianyu Sun
XHXian-Jing He
Xian-Jing He
CPChun-Yuan Pan
Chun-Yuan Pan
YLYan-Peng Liu
Yan-Peng Liu
YZYun-Peng Zou
Yun-Peng Zou

17 May 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
CYChaofu Yang
Chaofu Yang
JWJing Wang
Jing Wang
YCYunyun Cheng
Yunyun Cheng
XYXu Yang
Xu Yang
YFYan Feng
Yan Feng
XHXinhua He
Xinhua He

1 January 2019 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
XSXianyu Sun
Xianyu Sun
CZChun-Yan Zhong
Chun-Yan Zhong
QQQing-Qing Qiu
Qing-Qing Qiu
ZLZhen-Wang Li
Zhen-Wang Li
MLMei-Yu Liu
Mei-Yu Liu
CJCheng-Hao Jin
Cheng-Hao Jin
In this study, a series of 4,5-bis(substituted phenyl)-4H-1,2,4-triazol-3-amine compounds was designed, synthesised, and evaluated to determine their potential as anti-lung cancer agents. According to the results of screening of lung cancer cell lines A549, NCI-H460, and NCI-H23 in vitro, most of the synthesised compounds have potent cytotoxic activities with IC50 values ranging from 1.02 to 48.01 µM. Particularly, compound 4,5-bis(4-chlorophenyl)-4H-1,2,4-triazol-3-amine (BCTA) was the most potent anti-cancer agent, with IC50 values of 1.09, 2.01, and 3.28 µM against A549, NCI-H460, and NCI-H23 cells, respectively, meaning many-fold stronger anti-lung cancer activity than that of the chemotherapeutic agent 5-fluorouracil. We also explored the effects of BCTA on apoptosis in lung cancer cells by flow cytometry and western blotting. Our results indicated that BCTA induced apoptosis by upregulating proteins BAX, caspase 3, and PARP. Thus, the potential application of compound BCTA as a drug should be further examined. Graphical Abstract An outstanding compound BCTA (4,5-bis(4-chlorphenyl)-4H-1,2,4-triazol-3-amine) was found to possess more potent anticancer activity against several lung cancer cells than the reference drugs 5-FU. The effects of BCTA on apoptosis and necrosis in A549 cells were analysed by Hoechst/propidium iodide (PI) double staining and early and late apoptosis were analysed by Annexin V/PI flow cytometry. Further Western bloting results revealed that BCTA could induce cell apoptosis by down-regulting Bcl-2 protein.